Evidence map›Paper›PMID 35893381›Full record

ArticleJournal of clinical medicine2022

Mariola Herbet, Jarosław Widelski, Iwona Piątkowska-Chmiel, Kamil Pawłowski, Aleksandra Dymek, Tomasz Mroczek

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mariola HerbetDepartment of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0001-8975-8093
Jarosław WidelskiDepartment of Pharmacognosy with the Medicinal Plant Garden, Medical University of Lublin, 20-093 Lublin, Poland.
Iwona Piątkowska-ChmielDepartment of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 20-090 Lublin, Poland.
Kamil PawłowskiDepartment of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 20-090 Lublin, Poland.
Aleksandra DymekDepartment of Chemistry of Natural Products, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-5285-760X
Tomasz MroczekDepartment of Chemistry of Natural Products, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-5267-7182
Medical University of Lublin · PL

Funding

Funds for Statutory Activity of Medical University of Lublin 36/2020/2021
6 · The paper itself

Abstract

The study aimed to evaluate the safety and pharmacological activity

Indexed as

acetylcholinesterase inhibitorsAlzheimer’s diseaseAmaryllidaceae alkaloidscoumarinsinflammationLycopodiaceae alkaloids

Identifiers

PMID35893381
PMCPMC9332316
OpenAlexW4287010115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.